Northpond Ventures, LP 13D and 13G filings for DICE Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-06-23 5:10 pm Sale |
2023-06-22 | 13D | DICE Therapeutics, Inc. DICE |
Northpond Ventures, LP | 800,000 1.700% |
-2,492,871 (-75.71%) |
Filing |
| 2022-11-10 4:15 pm Unchanged |
2022-11-09 | 13D | DICE Therapeutics, Inc. DICE |
Northpond Ventures, LP | 3,292,871 6.900% |
0 (Unchanged) |
Filing |
| 2021-09-28 06:04 am Purchase |
2021-09-17 | 13D | DICE Therapeutics, Inc. DICE |
Northpond Ventures, LP | 3,292,871 9.100% |
3,292,871 (New Position) |
Filing |